|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.445 AUD | -1.37% |
|
-4.62% | +11.15% |
| Apr. 30 | Wilsons Upgrades Monash IVF to Overweight from Market-Weight, Price Target is AU$1.58 | MT |
| Apr. 12 | RBC Capital Markets Starts Monash IVF Group at New Sector Perform, Price Target is AU$1.50 | MT |
Monash IVF Group Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported net income was AUD 10.64 million compared to AUD 12.09 million a year ago. Basic earnings per share from continuing operations was AUD 0.027 compared to AUD 0.031 a year ago.
Diluted earnings per share from continuing operations was AUD 0.027 compared to AUD 0.031 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +11.15% | 374M | |
| -14.25% | 85.02B | |
| +14.46% | 82.37B | |
| +9.37% | 29.29B | |
| -11.40% | 17.21B | |
| -0.36% | 16.7B | |
| +0.22% | 15.5B | |
| +4.32% | 12.15B | |
| -2.34% | 12.13B | |
| +32.69% | 12.12B |
MONASH IVF GROUP LIMITED 
